Biobanking – Creating a Collaborative Approach between Academia & Industry

Add bookmark

In this interview Arndt Schmitz, Head of Research Biobank, Bayer Pharma AG, speaks to Andrea Charles from Pharma IQ about creating a collaborative approach between academia and industry, the associated hurdles when technology is transferred from academia to industry and measuring successful collaboration in biobanking. Pharma IQ: Why is collaboration important between the academia and industry? A Schmitz: I would say because the two sectors are complementary, and we can only achieve result...
To continue reading this story get free access

RECOMMENDED